Clinical Trial Update: A Phase 3 Study of Rotigotine in Combination with Rivastigmine in Mild to Moderate Alzheimer's Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating rotigotine in combination with rivastigmine for mild-to-moderate Alzheimer's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Rivastigmine (Rivastigmine)
• Rotigotine (rotigotine)

Snippet

Sponsor: I.R.C.C.S. Fondazione Santa Lucia | Conditions: Alzheimer Disease | Phase 3 | Status: RECRUITING